MUL1
Basic information
Region (hg38): 1:20499448-20508151
Previous symbols: [ "C1orf166" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MUL1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 24 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 24 | 1 | 3 |
Variants in MUL1
This is a list of pathogenic ClinVar variants found in the MUL1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-20500713-C-G | not specified | Uncertain significance (Oct 12, 2021) | ||
1-20500724-G-A | not specified | Uncertain significance (Feb 07, 2023) | ||
1-20500737-T-C | not specified | Uncertain significance (Feb 14, 2023) | ||
1-20500764-C-T | not specified | Uncertain significance (Apr 07, 2022) | ||
1-20500767-G-A | not specified | Uncertain significance (Dec 09, 2023) | ||
1-20500779-T-C | not specified | Uncertain significance (Feb 14, 2024) | ||
1-20500792-G-A | Likely benign (Jun 05, 2018) | |||
1-20500814-C-T | not specified | Uncertain significance (May 02, 2024) | ||
1-20500922-T-C | not specified | Uncertain significance (Mar 01, 2024) | ||
1-20500944-G-A | not specified | Uncertain significance (Dec 15, 2022) | ||
1-20501045-G-A | not specified | Uncertain significance (Feb 23, 2023) | ||
1-20501048-T-C | not specified | Uncertain significance (Feb 01, 2023) | ||
1-20501048-T-G | not specified | Uncertain significance (May 03, 2023) | ||
1-20501054-C-T | not specified | Uncertain significance (Jun 13, 2022) | ||
1-20501097-G-T | not specified | Uncertain significance (Aug 14, 2023) | ||
1-20501113-C-T | Benign (Dec 31, 2019) | |||
1-20501172-C-T | not specified | Uncertain significance (Jan 18, 2023) | ||
1-20501194-G-A | Benign (Jun 18, 2018) | |||
1-20501264-G-A | not specified | Uncertain significance (Aug 04, 2023) | ||
1-20501340-C-T | not specified | Uncertain significance (May 25, 2022) | ||
1-20501384-T-C | not specified | Uncertain significance (Feb 15, 2023) | ||
1-20502167-T-A | not specified | Uncertain significance (Jan 23, 2024) | ||
1-20503239-G-A | not specified | Uncertain significance (Dec 09, 2023) | ||
1-20503244-G-C | not specified | Uncertain significance (Mar 01, 2023) | ||
1-20503281-T-C | not specified | Uncertain significance (Jan 03, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MUL1 | protein_coding | protein_coding | ENST00000264198 | 4 | 8712 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000191 | 0.698 | 125692 | 0 | 56 | 125748 | 0.000223 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.857 | 176 | 211 | 0.834 | 0.0000128 | 2269 |
Missense in Polyphen | 58 | 72.875 | 0.79588 | 816 | ||
Synonymous | -1.03 | 104 | 91.5 | 1.14 | 0.00000552 | 725 |
Loss of Function | 1.12 | 11 | 15.8 | 0.696 | 9.11e-7 | 165 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000936 | 0.000936 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000162 | 0.000158 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000327 | 0.000327 |
Other | 0.000513 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Exhibits weak E3 ubiquitin-protein ligase activity (PubMed:18591963, PubMed:19407830, PubMed:22410793). E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfer the ubiquitin to targeted substrates (PubMed:18591963, PubMed:19407830, PubMed:22410793). Can ubiquitinate AKT1 preferentially at 'Lys-284' involving 'Lys-48'-linked polyubiquitination and seems to be involved in regulation of Akt signaling by targeting phosphorylated Akt to proteosomal degradation (PubMed:22410793). Proposed to preferentially act as a SUMO E3 ligase at physiological concentrations (PubMed:19407830). Plays a role in the control of mitochondrial morphology by promoting mitochondrial fragmentation, and influences mitochondrial localization (PubMed:19407830, PubMed:18207745, PubMed:18213395). Likely to promote mitochondrial fission through negatively regulating the mitochondrial fusion proteins MFN1 and MFN2, acting in a pathway that is parallel to the PRKN/PINK1 regulatory pathway (PubMed:24898855). May also be involved in the sumoylation of the membrane fission protein DNM1L (PubMed:18207745, PubMed:19407830). Inhibits cell growth (PubMed:18591963, PubMed:22410793). When overexpressed, activates JNK through MAP3K7/TAK1 and induces caspase-dependent apoptosis (PubMed:23399697). Involved in the modulation of innate immune defense against viruses by inhibiting DDX58-dependent antiviral response (PubMed:23399697). Can mediate DDX58 sumoylation and disrupt its polyubiquitination (PubMed:23399697). {ECO:0000269|PubMed:18207745, ECO:0000269|PubMed:18213395, ECO:0000269|PubMed:18591963, ECO:0000269|PubMed:19407830, ECO:0000269|PubMed:22410793, ECO:0000269|PubMed:23399697, ECO:0000269|PubMed:24898855}.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Ub-specific processing proteases;Deubiquitination
(Consensus)
Recessive Scores
- pRec
- 0.122
Intolerance Scores
- loftool
- 0.734
- rvis_EVS
- 0.02
- rvis_percentile_EVS
- 55.61
Haploinsufficiency Scores
- pHI
- 0.155
- hipred
- Y
- hipred_score
- 0.675
- ghis
- 0.484
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.872
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mul1
- Phenotype
Gene ontology
- Biological process
- mitochondrial fission;apoptotic process;activation of cysteine-type endopeptidase activity involved in apoptotic process;activation of JUN kinase activity;negative regulation of mitochondrial fusion;regulation of mitochondrion organization;protein ubiquitination;protein sumoylation;negative regulation of cell growth;protein destabilization;positive regulation of protein sumoylation;positive regulation of I-kappaB kinase/NF-kappaB signaling;negative regulation of innate immune response;negative regulation of defense response to virus by host;protein stabilization;mitochondrion localization;regulation of mitochondrial membrane potential;negative regulation of protein kinase B signaling;negative regulation of type I interferon-mediated signaling pathway;cellular response to exogenous dsRNA;negative regulation of chemokine (C-C motif) ligand 5 production;positive regulation of mitochondrial fission;regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway;positive regulation of dendrite extension;positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization
- Cellular component
- mitochondrion;peroxisome;membrane;axon;integral component of mitochondrial outer membrane;neuronal cell body
- Molecular function
- ubiquitin-protein transferase activity;protein binding;SUMO transferase activity;ubiquitin protein ligase binding;identical protein binding;metal ion binding